FFO
COCP icon

Fortitude Family Office’s Cocrystal Pharma COCP Stock Holding History

Fortitude Family Office’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,219
Closed -$3.15K – 1922
2025
Q4 		$3.15K Buy
+3,219
New +$3.41K ﹤0.01% 995

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Fortitude Family Office's COCP Position: Q1 2026 in Review

Fortitude Family Office sold out of Cocrystal Pharma (COCP) in Q1 2026, closing a stake of 3,219 shares — an estimated $3.15K sold.

Fortitude Family Office first reported a position in COCP in Q4 2025 and held it in 1 quarter. The position peaked at $3.15K in Q4 2025. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

  • Fortitude Family Office reported no remaining Cocrystal Pharma position as of Q1 2026 after selling out during the quarter.
  • Fortitude Family Office sold 3,219 Cocrystal Pharma shares in Q1 2026, an estimated $3.15K.
  • Fortitude Family Office first reported a position in Cocrystal Pharma in Q4 2025 and held it in 1 quarter.
  • Fortitude Family Office's Cocrystal Pharma position peaked at $3.15K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.